Sequestration of Muscarinic Cholinergic Receptors in Permeabilized Neuroblastoma Cells
dc.contributor.author | Slowiejko, Diana M. | en_US |
dc.contributor.author | Levey, Allan I. | en_US |
dc.contributor.author | Fisher, Stephen K. | en_US |
dc.date.accessioned | 2010-04-01T15:15:53Z | |
dc.date.available | 2010-04-01T15:15:53Z | |
dc.date.issued | 1994-05 | en_US |
dc.identifier.citation | Slowiejko, Diana M.; Levey, Allan I.; Fisher, Stephen K. (1994). "Sequestration of Muscarinic Cholinergic Receptors in Permeabilized Neuroblastoma Cells." Journal of Neurochemistry 62(5): 1795-1803. <http://hdl.handle.net/2027.42/65736> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65736 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8158129&dopt=citation | en_US |
dc.description.abstract | The feasibility of using a permeabilized preparation of human SH-SY-5Y neuroblastoma cells for studies of muscarinic acetylcholine receptor (mAChR) sequestration has been evaluated. Exposure of cells permeabilized with digitonin, streptolysin-O, or the Α-toxin from Staphylococcus aureus to oxotremorine-M (Oxo-M) for 30 min resulted in a 25–30% reduction in the number of cell surface mAChRs, as monitored by the loss of N [ 3 H]methyl- scopolamine ([ 3 H]NMS) binding sites. The corresponding value for intact cells was 40%. For cells permeabilized with 20 Μ M digitonin, the Oxo-M-mediated reduction in [ 3 H]NMS binding was time ( t 1/2 ∼ 5 min) and concentration (EC 50 ∼ 10 Μ M ) dependent and was agonist specific (Oxo M > bethanechol = arecoline = pilocarpine). In contrast, no reduction in total mAChR number, as monitored by the binding of [ 3 H]quinuclidinyl benzilate, occurred following Oxo-M treatment. The loss of [ 3 H]NMS sites observed in the presence of Oxo-M was unaffected by omission of either ATP or Ca 2+ , both of which are required for stimulated phosphoinositide hydrolysis, but could be inhibited by the inclusion of guanosine 5′- O -(2-thiodiphosphate). mAChRs sequestered in response to Oxo-M addition were unmasked when the cells were permeabilized in the presence of higher concentrations of digitonin (80 Μ M ). The results indicate (a) that permeabilized SH-SY-5Y cells support an agonist-induced sequestration of mAChRs, the magnitude of which is ∼ 65–70% of that observed for intact cells, (b) that when internalized, mAChRs are located in a cellular compartment to which [ 3 H]NMS has only a limited access despite the removal of the plasma membrane barrier, and (c) that the production of phosphoinositide-derived second messengers is not a prerequisite for mAChR sequestration. | en_US |
dc.format.extent | 1019754 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1994 International Society for Neurochemistry | en_US |
dc.subject.other | Human SH-SY-5Y Neuroblastoma | en_US |
dc.subject.other | Muscarinic Cholinergic Receptor Internalization | en_US |
dc.subject.other | Phosphoinositide Hydrolysis | en_US |
dc.subject.other | Digitonin Permeabilization | en_US |
dc.title | Sequestration of Muscarinic Cholinergic Receptors in Permeabilized Neuroblastoma Cells | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Neuroscience Laboratory and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan; | en_US |
dc.contributor.affiliationother | * Department of Neurology, Emory University, Atlanta, Georgia, U.S.A. | en_US |
dc.identifier.pmid | 8158129 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65736/1/j.1471-4159.1994.62051795.x.pdf | |
dc.identifier.doi | 10.1046/j.1471-4159.1994.62051795.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Ahnert-Hilger G., Mach W., FÖhr K. J., and Gratzl M. ( 1989 ) Poration by Α-toxin and streptolysin O: an approach to analyze intracellular processes. Methods Cell Biol. 31, 63 – 90. | en_US |
dc.identifier.citedreference | Baumgold J., Cooperman B. B., and White T. M. ( 1989 ) Relationship between desensitization and sequestration of muscarinic cholinergic receptors in two neuronal cell lines. Neuropharmacology 28, 1253 – 1261. | en_US |
dc.identifier.citedreference | Cioffi C. L., and EI-Fakahany E. E. ( 1989 ) Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Biochem. Pharmacol. 38, 1827 – 1834. | en_US |
dc.identifier.citedreference | Cioffi C. L., and Fisher S. K. ( 1990 ) Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY-5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein. J. Neurochem. 54, 1725 – 1734. | en_US |
dc.identifier.citedreference | Feigenbaum P. and EI-Fakahany E. E. ( 1985 ) Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function. J. Pharmacol. Exp. Ther. 233, 134 – 140. | en_US |
dc.identifier.citedreference | Fisher S. K. ( 1988 ) Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity and the presence of agonists. Mol. Pharmacol. 33, 414 – 422. | en_US |
dc.identifier.citedreference | Fisher S. K., and Heacock A. M. ( 1988 ) A putative M 3 muscarinic cholinergic receptor of high molecular weight couples to phosphoinositide hydrolysis in human SK-N-SH neuroblastoma cells. J. Neurochem. 50, 984 – 987. | en_US |
dc.identifier.citedreference | Fisher S. K., and Snider R. M. ( 1987 ) Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas. Mol. Pharmacol. 32, 81 – 90. | en_US |
dc.identifier.citedreference | Fisher S. K., Domask L. M., and Roland R. M. ( 1989 ) Muscarinic receptor regulation of cytoplasmic Ca 2+ concentrations in human SK-N-SH neuroblastoma cells: Ca 2+ requirements for phospholipase C activation. Mol. Pharmacol. 35, 195 – 204. | en_US |
dc.identifier.citedreference | Fisher S. K., Heacock A. M., Seguin E. B., and Agranoff B. W. ( 1990 ) Polyphosphoinositides are the major source of inositolphosphates in carbamoylcholine-stimulated SK-N-SH neuroblastoma cells. Mol. Pharmacol. 38, 54 – 63. | en_US |
dc.identifier.citedreference | Fisher S. K., Slowiejko D. M., and McEwen E. L. ( 1994 ) A rapid attenuation of muscarinic agonist stimulated phosphoinositide hydrolysis precedes receptor sequestration in human SH- SY-5Y neuroblastoma cells. Neurochem. Res. 19, 551 – 556. | en_US |
dc.identifier.citedreference | Fraeyman N. H., and Buyse M.-A. ( 1989 ) Gradient distribution pattern of muscarinic receptors in N1E 115 mouse neuroblastoma cells. Experientia 45, 742 – 747. | en_US |
dc.identifier.citedreference | Fratelli M., Gagliardini V., and De Blasi A. ( 1989 ) Low affinity of Β-adrenergic receptors for agonists on intact cells is not due to receptor sequestration. Biochim. Biophys. Acta 1012, 178 – 183. | en_US |
dc.identifier.citedreference | Frey K. A. ( 1984 ) The in vivo determination of ligand binding within the central nervous system [ Ph.D. Thesis ]. University of Michigan, Ann Arbor. | en_US |
dc.identifier.citedreference | Geiger P. J., and Bessman S. P. ( 1972 ) Protein determination by Lowry's method in the presence of sulfhydryl reagents. Anal Biochem. 49, 467 – 474. | en_US |
dc.identifier.citedreference | Harden T. K., Fetch L. A., Traynelis S. F., and Waldo G. L. ( 1985 ) Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors. J. Biol. Chem. 260, 13060 – 13066. | en_US |
dc.identifier.citedreference | Hertel C., Staehelin M., and Perkins J. P. ( 1983 ) Evidence for intravesicular Β-adrenergic receptors in membrane fractions from desensitized cells: binding of the hydrophilic ligand CGP- 12177 only in the presence of alamethicin. J. Cyclic Nucleotide Protein Phosphorylation Res. 9, 119 – 128. | en_US |
dc.identifier.citedreference | Lambert D. G., and Nahorski S. R. ( 1990 ) Muscarinic-receptor-me- diated changes in intracellular Ca 2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY-5Y. Biochem. J. 265, 555 – 562. | en_US |
dc.identifier.citedreference | Lambert D. G., Ghataorre A. S., and Nahorski S. R. ( 1989 ) Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY-5Y and SH-EP1. Eur. J. Pharmacol. 165, 71 – 77. | en_US |
dc.identifier.citedreference | Lameh J., Philip M., Sharma Y. K., Moro O., Ramachandran J., and SadÉe W. ( 1992 ) Hml muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. J. Biol. Chem. 267, 13406 – 13412. | en_US |
dc.identifier.citedreference | Levey A. I., Stormann T. M., and Brann M. R. ( 1990 ) Bacterial expression of human muscarinic receptor fusion proteins and generation of subtype-specific antisera. FEBS Lett. 275, 65 – 69. | en_US |
dc.identifier.citedreference | Levey A. I., Kitt C. A., Simonds W. F., Price D. L., and Brann M. R. ( 1991 ) Identification and localization of muscarinic acetylcholine receptor proteins in brain and subtype-specific antibodies. J. Neurosci. 11, 3218 – 3226. | en_US |
dc.identifier.citedreference | Lohse M. J., Benovic J. L., Caron M. G., and Lefkowitz R. J. ( 1990 ) Multiple pathways of rapid Β 2 -adrenergic receptor desensitization. J. Biol. Chem. 265, 3203 – 3209. | en_US |
dc.identifier.citedreference | Nantel F., Bonin H., Emorine L. J., Zilberfarb V., Strosberg A. D., Bouvier N., and Naurullo S. ( 1993 ) The human Β 3 -adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol. Pharmacol. 43, 548 – 555. | en_US |
dc.identifier.citedreference | Sarafian T., Aunis D., and Bader M.-F. ( 1987 ) Loss of proteins from digitonin-permeabilized adrenal chromaffin cells essential for exocytosis. J. Biol. Chem. 262, 16671 – 16676. | en_US |
dc.identifier.citedreference | Serra M., Mei L., Roeske W. R., Lui G. K., Watson M., and Yamamura H. I. ( 1988 ) The intact neuroblastoma cell (SH-SY-5Y) exhibits high-affinity [ 3 H]pirenzepine binding associated with hydrolysis of phosphatidylinositols. J. Neurochem. 50, 1513 – 1521. | en_US |
dc.identifier.citedreference | Slowiejko D. M., and Fisher S. K. ( 1993 ) Muscarinic agonists induce a loss of hydrophilic binding sites from both intact and permeabilized neuroblastoma. Trans. Am. Soc. Neurochem. 24, 106. | en_US |
dc.identifier.citedreference | Suzuki T., Nguyen C. T., Nantel F., Bonin H., Valiquette M., Frielle T., and Bouvier M. ( 1992 ) Distinct regulation of Β 1 - and Β 2 -adrenergic receptors in Chinese hamster-fibroblasts. Mol. Pharmacol. 41, 542 – 548. | en_US |
dc.identifier.citedreference | Thompson A. K., and Fisher S. K. ( 1990 ) Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations. J. Pharmacol. Exp. Ther. 252, 744 – 752. | en_US |
dc.identifier.citedreference | Thompson A. K., and Fisher S. K. ( 1991 ) Preferential coupling of cell surface muscarinic receptors to phosphoinositide hydrolysis in human neuroblastoma cells. J. Biol. Chem. 266, 5004 – 5010. | en_US |
dc.identifier.citedreference | Thompson A. K., Mostafapour S. P., Denlinger L. C., Bleasdale J. E., and Fisher S. K. ( 1991 ) The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J. Biol. Chem. 266, 23856 – 23862. | en_US |
dc.identifier.citedreference | von Zastrow M. and Kobilka B. K. ( 1992 ) Ligand-regulated internalization and recycling of human Β 2 -adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. Biol. Chem. 267, 3530 – 3538. | en_US |
dc.identifier.citedreference | Wall S. J., Yasuda R. P., Li M., and Wolfe B. B. ( 1991 ) Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Mol. Pharmacol 40, 783 – 789. | en_US |
dc.identifier.citedreference | Wojcikiewicz R. J. H., Lambert D. G., and Nahorski S. R. ( 1990a ) Regulation of muscarinic agonist-induced activation of phosphoinositidase C in electrically permeabilized SH-SY5Y human neuroblastoma cells by guanine nucleotides.. J. Neurochem. 54, 676 – 685. | en_US |
dc.identifier.citedreference | Wojcikiewicz R. J. H., Safrany S. T., Challiss R. A. J., Strupish J., and Nahorski S. R. ( 1990b ) Coupling of muscarinic receptors to the mobilization of intracellular Ca 2+ stores in permeabilized SH-SY5Y human neuroblastoma cells.. Biochem. J. 272, 269 – 272. | en_US |
dc.identifier.citedreference | Wroblewski F. and LaDue J. S. ( 1955 ) Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90, 210 – 213. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.